Wednesday, November 28, 2018 9:44:51 AM
LOS ANGELES, CA / ACCESSWIRE / November 28, 2018 / Know Labs, Inc. (OTCQB: KNWN), a provider of diagnostic solutions, today announced that it will be presenting at the 11th annual LD Micro Main Event on Thursday, December 6 at 10:30 AM PST / 1:30 PM EST. CEO, Phil Bosua and Chairman, Ron Erickson, will be presenting and meeting with investors.
Know Labs has created groundbreaking technology that can non-invasively detect blood glucose levels, among other biomarkers. Bosua stated, "We've invented a holy grail of the bio-tech industry - non-invasive - blood glucose monitoring. Our prototype sensor can detect blood glucose levels, but not with finger pricks - it's completely non-invasive."
Bosua explains further, "We originally set out to detect blood glucose and in turn, created a platform. We've begun initial research to measure all types of substances in the blood and interstitial fluid. Biomarkers like cortisol for stress levels, as well as continuous measurement of the luteinizing hormone, which would indicate ovulation within the next 4 hours - ideal for those wanting to get pregnant. We're now ahead of schedule and look forward to creating the future of non-invasive health measurements." Know Labs is excited to be presenting at LD Micro.
"Internally, our entire year leads up to the Main Event. It has become the 'one thing' everyone in the small and micro-cap world knows us for. Also, free mints" stated Chris Lahiji, while enjoying a mint. "Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the most interesting businesses in the world to our ever growing community."
The LD Micro Main Event will take place December 4th, 5th, and 6th, in Los Angeles at the Luxe Sunset Bel Air Hotel, will feature 250 companies, and will be attended by over 1,200 individuals.
View Know Lab's profile here: https://www.ldmicro.com/profile/KNWN
Recent KNW News
- Know Labs to Present Clinical Research at the 2024 American Physiology Summit • Business Wire • 04/05/2024 01:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:10:40 PM
- Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study • Business Wire • 03/06/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:17:42 PM
- Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives • Business Wire • 02/29/2024 09:15:00 PM
- Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor • Business Wire • 02/27/2024 04:44:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 02:03:51 PM
- Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor • Business Wire • 02/27/2024 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:17:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:15:26 PM
- Know Labs, Inc. Reports First Quarter FY2024 Results • Business Wire • 02/14/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:23:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:22:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:20:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:19:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:18:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:17:03 PM
- Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024 • Business Wire • 02/07/2024 02:00:00 PM
- Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) • Business Wire • 01/23/2024 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/12/2024 05:15:08 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:16:39 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:15:52 PM
- Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results • Business Wire • 12/19/2023 09:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/19/2023 09:03:19 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM